+ Translate

Evidence of altered dopaminergic modulation of prolactin luteinizing hormone and tsh secretion in patients with normo prolactinemic amenorrhea

, : Evidence of altered dopaminergic modulation of prolactin luteinizing hormone and tsh secretion in patients with normo prolactinemic amenorrhea. Acta Endocrinologica 106(1): 8-14

Basal plasma concentrations of Prl, [prolactin], LH [luteinizing hormone], FSH, growth hormone, TSH, T3, T4, [triiodothyronine, thyroxine] resin T3 uptake (RT3U), and estradiol as well as hormone responses to i.v. metoclopramide (MTC) were investigated in 16 consecutive patients with normoprolactinemic, normogonadotropic amenorrhea. The control group consisted of 17 normal menstruating women between day 3 and 6 of the menstrual cycle. The mean age of the amenorrheic patients was 24.0 yr (range 19-34) and the mean duration of amenorrhea was 31 mo. (range 12-60). Amenorrheic patients had significantly (P < 0.05) lower basal levels of LH, estradiol and RT3U, whereas other hormone levels were similar in the 2 groups. Plasma Prl and TSH concentrations rose significantly (P < 0.05) after the administration of MTC in the 2 groups. A significant positive correlation (r = 0.69 P < 0.01) was found between the TSH response to MTC and basal TSH levels in controls, but not in amenorrheic patients. Plasma LH levels increased significantly (P < 0.05) in amenorrheic patients, but not in controls. The Prl and TSH responses to MTC were significantly (P < 0.001) lower in amenorrheic patients than in normal women. In amenorrheic patients none of the hormonal parameters correlated significantly (P > 0.05) with the percentage of ideal body weight. The hormonal changes in amenorrheic patients may in part be caused by a raised dopaminergic activity leading to a depression of central ovulatory mechanisms.

(PDF 0-2 workdays service)

Accession: 005411210

Submit PDF Full Text: Here

Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:

Related references

Hagen C.; Andersen A.N.; Djursing H., 1984: Evidence of altered dopaminergic modulation of prolactin luteinizing hormone fsh growth hormone and tsh secretion during chronic partial dopamine receptor blockade in normal women. To study the influence of chronic, partial dopaminergic blockade on pituitary secretion of Prl [prolactin], TSH, GH, LH [growth hormone, luteinizing hormone] and FSH, 8 normally menstruating women were given metoclopramide (MTC) 7.5 mg daily for 4...

Djursing H.; Hagen C.; Christensen F.; Nickelsen C., 1981: Bromocriptine and estrogen modulation of gonadotropin release in normo prolactinemic and hyper prolactinemic patients with amenorrhea. Effects of estradiol, bromocriptine, and bromocriptine plus estradiol, on basal and GnRH [gonadotropin releasing hormone] stimulated gonadotropin concentrations were studied in normo- (group 1, n = 7) and hyperprolactinemic (group 2, n = 6) patien...

Takada M.; Aono T.; Tsutsumi H.; Koike K.; Miyake A.; Kurachi K., 1981: Ovarian response to short term and long term administration of exogenous gonadotropin in patients with hyper prolactinemic amenorrhea comparison with women with normo prolactinemic amenorrhea. Fertility & Sterility 35(5): 590-591

Portioli I.; Modena G.; Manicardi V.; Valcavi R.; Dotti C., 1979: Sulpiride a test for prolactin secretion in normo prolactinemic and hyper prolactinemic subjects. Spano, P F , Et Al (Ed ) Italian Brain Research Foundation Monograph Series: Sulpiride And Other Benzamides: Experimental And Clinical Pharmacology; International Workshop, Florence, Italy, Feb 17-18, 1978 Xiii+312p Italian Brain Research Foundation Press: Milan, Italy (Dist in The Usa By Raven Press: New York, N Y ) Illus : p175-184

Evans, W.S.; Rogol, A.D.; Macleod, R.M.; Thorner, M.O., 1980: Dopaminergic mechanisms and luteinizing hormone secretion 1. acute administration of the dopamine agonist bromocriptine does not inhibit luteinizing hormone release in hyper prolactinemic women. The concept that dopaminergic mechanisms control LH [luteinizing hormone] secretion by modulation of gonadotropin-releasing hormone (GnRH) was recently investigated in man. Since hyperprolactinemia is associated with increased hypothalamic dopamin...

Buckman M.T.; Peake G.T.; Srivastava L., 1981: Patterns of spontaneous luteinizing hormone release in normo prolactinemic and hyper prolactinemic women. Hyperprolactinemia may be associated with functional amenorrhea. To evaluate the possible role of abnormal spontaneous LH [luteinizing hormone] secretion in hyperprolactinemic amenorrheic women, plasma LH was measured at 15-min intervals for 300 m...

Velardo, A.; Pantaleoni, M.; Zironi, C.; Zizzo, G.; Marrama, P., 1991: Evidence of altered dopaminergic modulation of prolactin and thyrotropin secretion in patients with polycystic ovary syndrome. In order to evaluate the functional activity of the tubero-infundibular dopaminergic system in polycystic ovary syndrome (PCOS), we analysed the prolactin (PRL) and thyrotropin (TSH) responses to the dopamine antagonist sulpiride. We studied 8 eut...

Nappi, C.; Mercorio, F., 1980: Evaluation of the estrogen-prolactin positive feedback and ovarian sensitivity to treatment with gonadotropins in normo- and hyper-prolactinemic amenorrhea patients (preliminary note). Archivio di Ostetricia E Ginecologia 85(3): 155-156

Glass, M.R.; Shaw, R.W.; Williams, J.W.; Butt, W.R.; Logan-Edwards, R.; London, D.R., 1976: The control of gonadotropin release in women with hyper prolactinemic amenorrhea effect of estrogen and progesterone on the luteinizing hormone and follicle stimulating hormone response to luteinizing hormone releasing hormone. The effect of the administration of estradiol benzoate and of progesterone on the subsequent response to LHRH [luteinizing hormone-releasing hormone] was investigated in women with hyperprolactinemia. There was an amplification in the release of L...

Mcneilly A.S.; D.K.etser D.M.; Sharpe R.M., 1979: Modulation of prolactin luteinizing hormone and follicle stimulating hormone secretion by luteinizing hormone releasing hormone and bromocriptine cb 154 in the hypophysectomized pituitary grafted male rat and its effect on testicular luteinizing hormone receptors and testosterone output. Hypophysectomized adult male rats with a pituitary transplant under the kidney capsule were used to study the effects of chronic treatment with LHRH [luteinizing hormone-releasing hormone], with or without CB154, on the secretion of LH [lutropin],...